Regency Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,000	Closed	-$69K	–	52
2023 Q3	$69K	Hold	13,000	–	–	0.06%	44
2023 Q2	$124K	Buy	+13,000	New	+$124K	0.11%	43